drugset / Trial / NCT06450925
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators hypothesize that single oral high dose supplementation with vitamin A will reduce the incidence of moderate-severe chronic graft-versus-host disease (GVHD) compared with placebo.
Timeline
- Start
- 2025-03-25
- Primary completion
- 2027-08
- Completion
- 2029-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vitamin A | Unknown | 1.2 mg/kg | Oral |